With all this amazing science  FDA BTD, Cell publication for Covid mouse data, postive science data of  publication after publication why is RVX completely invisible to the markets.    Using Repare Therapeutics as model for  a Canadian succesful small Biotech company using their resources and proper  managment and marketing and Investment banking etc etc they have garnered a respectable market cap for their Company and science.   Do you think DM can make the changes necessary to get to where Repare is at this point. The Eversana partnership was a good start but not enough yet.  I am not too sure Hepalink and other possible insiders want to see that happen yet. The conspiratist in me thinks that Hepalink would love to take over RVX for peanuts and go private once they get over 50% ownership  if they can ,  IMHO